# Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer

> **NCT00125359** · PHASE2 · COMPLETED · sponsor: **Konstantin Dragnev** · enrollment: 42 (actual)

## Conditions studied

- Carcinoma, Non-small-cell Lung

## Interventions

- **DRUG:** erlotinib and bexarotene

## Key facts

- **NCT ID:** NCT00125359
- **Lead sponsor:** Konstantin Dragnev
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2019-01-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00125359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00125359, "Study of Tarceva and Targretin Oral Capsules in Patients With Advanced Lung Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00125359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*